ABIVAX Société Anonyme announced that it has received ?150 million in funding from Kreos Capital Management (UK) Limited, Claret Capital Partners, Heights Capital Management, Inc.

ABIVAX Société Anonyme announced a private placement for the gross proceeds of ?150 million on August 29, 2023. The transaction included participation from new investors Heights Capital Management, Inc. for ?75 million, Claret Capital Partners and returning investor Kreos Capital Management (UK) Limited for ?75 million. The company received ?75 million in two equal tranches.